Preclinical scientific tests counsel that retatrutide could impact weight problems-related cancer progression. Inside a research led by Marathe et al., retatrutide-induced weightloss lowered tumor engraftment, delayed tumor onset, and substantially attenuated tumor development in pancreatic and lung cancer models, with larger tumor suppression in c